A PHASE I TRIAL OF BTK INHIBITOR PCI-32765 IN PATIENTS WITH RELAPSED NON-HODGKIN'S LYMPHOMA: EVIDENCE OF ANTITUMOR ACTIVITY Fowler, N., Sharman, J., Smith, S., Pollyea, D., Boyd, T., Grant, B., Kathryn, K., Buggy, J., Loury, D., Hamdy, A., Advani, R. FERRATA STORTI FOUNDATION. 2010: 371

View details for Web of Science ID 000279051301214